IASLC World Conference on Lung Cancer

Understanding the Importance of Biomarker Testing in Lung Cancer

September 16th 2025, 8:00pm

Video

Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing.

Patient Advocate and Caregiver Shares Advocacy Journey in KRAS Cancers

September 15th 2025, 1:00pm

Video

Dr. Joshua Sabari spoke with advocate Chris Conneran on his journey from caregiver to champion for KRAS-mutant cancer patients and families.

Real-World Study Finds Benefit of Lutathera in Patients With Lung NETs

September 14th 2025, 2:00pm

Article

Lutathera demonstrated antitumor activity in patients with metastatic bronchopulmonary neuroendocrine tumors.

Tepmetko Associated With Frequent Side Effects for Some With NSCLC

September 13th 2025, 6:00pm

Article

For patients with MET exon 14-altered NSCLC, Tepmetko was associated with frequent side effects, although the safety profile is considered manageable.

Using AI to Improve Clinical Trial Access for Those With Lung Cancer

September 12th 2025, 8:00pm

Video

Dr. Josh Sabari and Max Doppelt explore challenges in trial enrollment and the potential of emerging therapies to offer hope for patients diagnosed today.

THIO Plus Libtayo Elicits Positive Responses in Advanced NSCLC

September 12th 2025, 3:00pm

Article

For patients with advanced non-small cell lung cancer who progressed on two or more prior regimens, THIO with Libtayo elicited positive responses.

Study Explores THIO Plus Immunotherapy in Advanced Lung Cancer

September 12th 2025, 1:00pm

Video

Dr. Thomas Jankowski explained that THIO, a telomerase inhibitor, is being studied with Libtayo to help overcome resistance in advanced lung cancer.

What Patients With Lung Cancer Need to Know About EGFR PACC Mutations

September 10th 2025, 1:00pm

Video

CURE spoke with Dr. Xiuning Le during the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer.

What Patients With Lung Cancer Need to Know About KRAS G12C Mutations

September 8th 2025, 8:00pm

Video

CURE spoke with Dr. Alexander Spira to learn what patients need to know about the KRAS G12C mutation and its treatment strategies.

Ivonescimab Plus Chemo Delays NSCLC Progression

September 8th 2025, 7:00pm

Article

In patients with EGFR-mutated NSCLC ivonescimab plus chemotherapy was associated with significant progression-free survival.